Android app Apple app link

AstraZeneca (LSE:AZN) Gains EU Recommendation For Imfinzi in Bladder Cancer Treatment

By Yahoo! Finance   |   4 weeks ago
AstraZeneca (LSE:AZN) Gains EU Recommendation For Imfinzi in Bladder Cancer Treatment

AstraZeneca's cancer therapy Imfinzi received a positive recommendation from the European Medicines Agency, boosting its oncology portfolio. Despite flat stock movement due to market trends, the company's AI collaborations and treatment expansions offer support amidst volatility.

Read More

Did you find this insightful?

Exclusive Content

Access to this content is reserved for premium members. Unlock all features by upgrading to a premium membership.

Get the App

To join as a premium member, please download our app and complete your membership purchase there.